Good morning :)
Switch to
Place Order

GlaxoSmithKline Pharmaceuticals Ltd

GLAXO
Health CarePharmaceuticals
MidcapWith a market cap of ₹24,443 cr, stock is ranked 193
Low RiskStock is 1.48x as volatile as Nifty
1,442.900.16% (-2.35)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹24,443 cr, stock is ranked 193
Low RiskStock is 1.48x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
14.429.186.24%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

43%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+3.28+3.85+3.14+4.70+0.45+0.09+0.36+1.69
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Newspaper Advertisements 
Announced OnJul 27, 2022

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements | Download

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Newspaper Advertisements | Download

Annual General Meeting 
Announced OnJul 26, 2022

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 26-Jul-2022 | Download

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Voting results, Scrutinizer report and Proceedings of Annual General Meeting held on 26-Jul-2022 | Download

Cash Dividend 
Ex. DateJul 7, 2022

Special • Div/Share: ₹ 60

See all events